SPIMACO Shareholders Approve 3.5% Dividend for 2025

Shareholders of Saudi Pharmaceutical Industries & Medical Appliances Corp. (SPIMACO) approved a cash dividend for 2025 at 3.5% of capital, or SAR 0.35 per share, the company said in a filing to the Saudi stock exchange. The approval came at the annual general meeting.

The dividend is the same rate as the 2024 payout, reflecting steady cash generation from SPIMACO's drug distribution and medical equipment supply business. The company has paid a dividend every year since 2015. It operates across Saudi Arabia, serving public hospitals and private pharmacies, with a smaller manufacturing arm in Riyadh.

The record date for the dividend has not been set. Payment will be made to shareholders on the register as of that date, following Tadawul's T+2 settlement cycle. Based on past practice, the payment is expected within 30 days of the record date.

The Tadawul All Share Index has a dividend yield of roughly 3.2%, according to exchange data. SPIMACO's 3.5% payout is slightly above that average, which may appeal to income-focused investors. The company's debt-free balance sheet supports its dividend policy even when earnings fluctuate.